Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal bupivacaine erector spinae plane block for chronic pain after thoracoscopic surgery
ChiCTR2500115654Phase 4Recruiting
- Sponsor
- Affiliated Suzhou Hospital of Nanjing Medical University
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of bupivacaine in postoperative pain (3 arms), sponsored by Affiliated Suzhou Hospital of Nanjing Medical University. Primary endpoint: Incidence of chronic pain 3 months after surgery. Started Dec 2025; status: recruiting.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2500115654.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500115654.